The NCE period for tirzepatide runs through May 13, 2027, which means generic companies may not file an ANDA seeking approval for a generic version of Mounjaro or Zepbound until May 13, 2026, with patent infringement lawsuits expected to occur in the following months
T.TortiF
B sung collagen, gip da sn chc v ti tr, ci thin cu trc da
Abbasinejad incorporates tirzepatide into a holistic weight loss strategy
However, advertising and sponsorship arrangements entered into by universities and conferences outside those contexts (e.g., regular season, conference championships, etc.) are not subject to NCAA review or approval. Technically, that means the College Football Playoff, conferences and their broadcast partners dont have to honor NCAA advertising guidelines